Omics analysis of HIV during synthetic opioid exposure

合成阿片类药物暴露期间 HIV 的组学分析

基本信息

  • 批准号:
    10158901
  • 负责人:
  • 金额:
    $ 15.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

Abstract In December 2019, an outbreak of pneumonia of unknown cause occurred in Wuhan, China, and the causative agent was identified as a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Additionally, the US is in the midst of a major opioid epidemic largely attributed to synthetic opioids such as fentanyl, and the SARS-CoV-2 pandemic is occurring in parts of the world where recent increases in HIV due to the opioid crisis have been reported. With the SARS-CoV-2 pandemic, there are major concerns about worsening of the opioid crisis. People suffering from addiction are particularly vulnerable to increased infection with SARS-CoV-2 and more advanced disease severity. Many opioids are also associated with immune suppression and enhanced viral pathogenesis. Thus, foundational research on virus-virus and virus-opioid interactions is essential for understanding the impact of SARS-CoV-2 on other co- morbid conditions and for developing robust therapeutic options for limiting viral infection and pathogenesis in high-risk populations.
摘要

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines.
  • DOI:
    10.3390/v15041027
  • 发表时间:
    2023-04-21
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Madhuravasal Krishnan J;Kong L;Karns R;Medvedovic M;Sherman KE;Blackard JT
  • 通讯作者:
    Blackard JT
Drugs of Abuse and Their Impact on Viral Pathogenesis.
  • DOI:
    10.3390/v13122387
  • 发表时间:
    2021-11-29
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Blackard JT;Sherman KE
  • 通讯作者:
    Sherman KE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON T BLACKARD其他文献

JASON T BLACKARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON T BLACKARD', 18)}}的其他基金

Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
  • 批准号:
    10542286
  • 财政年份:
    2022
  • 资助金额:
    $ 15.02万
  • 项目类别:
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
  • 批准号:
    10700069
  • 财政年份:
    2022
  • 资助金额:
    $ 15.02万
  • 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
  • 批准号:
    10203959
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
  • 批准号:
    10434701
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
  • 批准号:
    10653831
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
  • 批准号:
    10029242
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Omics analysis of HIV during synthetic opioid exposure
合成阿片类药物暴露期间 HIV 的组学分析
  • 批准号:
    10548205
  • 财政年份:
    2019
  • 资助金额:
    $ 15.02万
  • 项目类别:
Omics analysis of HIV during synthetic opioid exposure
合成阿片类药物暴露期间 HIV 的组学分析
  • 批准号:
    9883771
  • 财政年份:
    2019
  • 资助金额:
    $ 15.02万
  • 项目类别:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
基因型
  • 批准号:
    9267990
  • 财政年份:
    2013
  • 资助金额:
    $ 15.02万
  • 项目类别:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
基因型
  • 批准号:
    8466568
  • 财政年份:
    2013
  • 资助金额:
    $ 15.02万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 15.02万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 15.02万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 15.02万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 15.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 15.02万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 15.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了